In this study, we observed the development of NASH in HFD-fed eNOS-/- mice, a novel finding that adds to previous reports showing that these mice exhibit the typical features of the metabolic syndrome such as weight gain, insulin resistance, and hypertension [5]. The gene discussed is NOS3; the disease is metabolic dysfunction-associated steatohepatitis.